Jun 18, 2026 05:51AM
Jun 18, 2026 05:51AM
Jun 18, 2026 04:00AM
Jun 18, 2026 04:00AM
Jan 6, 2026 07:16AM
Jan 6, 2026 07:15AM
Aug 13, 2025 04:15PM Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Jul 9, 2025 04:30AM
Jul 9, 2025 04:30AM
Jun 11, 2025 04:19PM
Jun 11, 2025 04:17PM
Jun 4, 2025 10:29PM
May 21, 2025 07:22AM
May 7, 2025 04:45PM Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
Mar 26, 2025 06:34PM
Mar 20, 2025 11:43AM
Mar 20, 2025 03:00AM
Mar 20, 2025 03:00AM
Nov 13, 2024 04:05PM
May 20, 2024 08:25PM
May 20, 2024 08:25PM Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Feb 29, 2024 04:05PM
Feb 29, 2024 04:05PM
Feb 26, 2024 05:52AM
Feb 26, 2024 04:25AM
Feb 25, 2024 08:36PM
Feb 23, 2024 08:15PM
Feb 23, 2024 08:15PM Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Feb 15, 2024 06:31AM
Feb 15, 2024 06:30AM
Feb 14, 2024 12:15PM
Jan 29, 2024 05:55AM
Jan 29, 2024 04:00AM
Jan 19, 2024 11:30AM
Jan 19, 2024 11:30AM Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
Jan 19, 2024 11:30AM
Jan 3, 2024 04:25AM
Jan 3, 2024 03:30AM
Nov 29, 2023 04:00AM
Nov 28, 2023 04:15PM
Nov 14, 2023 07:02AM
Nov 14, 2023 07:00AM Alvotech (ALVO) and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki (AVT04), the First Biosimilar of Stelara
Nov 14, 2023 07:00AM
Nov 14, 2023 07:00AM
Oct 12, 2023 04:00AM
Sep 25, 2023 04:00AM
Sep 25, 2023 04:00AM
Aug 29, 2023 05:27AM
Aug 29, 2023 05:00AM Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) in Egypt
Jul 31, 2023 05:43AM

1,159,971 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All